Quantification of biopharmaceuticals and biomarkers in complex biological matrices: a comparison of liquid chromatography coupled to tandem mass spectrometry and ligand binding assays

References

• An B, Zhang M, Qu J. Toward sensitive and accurate analysis of antibody biotherapeutics by liquid chromatography coupled with mass spectrometry. Drug Metab Dispos 2014;42:1858-66
   PubMedGoogle Scholar
• Barton C, Kay RG, Gentzer W. Development of high-throughput chemical extraction techniques and quantitative HPLC-MS/MS (SRM) assays for clinically relevant plasma proteins. J Proteome Res 2010;9(1):333-40
   PubMed Web of Science ®Google Scholar
• Becker JO, Hoofnagle AN. Replacing immunoassays with tryptic digestion-peptide immunoaffinity enrichment and LC-MS/MS. Bioanalysis 2012;4:281-90
   PubMed Web of Science ®Google Scholar
• Bronsema KJ, Bischoff R, Merbel NC. Internal standards in the quantitative determination of protein biopharmaceuticals using liquid chromatography coupled to mass spectrometry. J Chromatogr B 2012;893-894:1-14
   PubMed Web of Science ®Google Scholar
• Bronsema KJ, Bischoff R, van de Merbel NC. High-sensitivity LC-MS/MS quantification of peptides and proteins in complex biological samples: the impact of enzymatic digestion and internal standard selection on method performance. Anal Chem 2013;85:9528-35
   PubMed Web of Science ®Google Scholar
• Bystrom CE, Salameh W, Reitz R, Clarke NJ. Plasma renin activity by LC-MS/MS: development of a prototypical clinical assay reveals a subpopulation of human plasma samples with substantial peptidase activity. Clin Chem 2010;56:1561-9
   PubMed Web of Science ®Google Scholar
• Campbell JL, Blanc JC. Peptide and protein drug analysis by MS: challenges and opportunities for the discovery environment. Bioanalysis 2011;3:645-57
   PubMedGoogle Scholar
• Chappell DL, Lassman ME, McAvoy T, et al. Quantitation of human peptides and proteins via MS: review of analytically validated assays. Bioanalysis 2014;6:1843-57
   PubMed Web of Science ®Google Scholar
• Damen CW, Schellens JH, Beijnen JH. Bioanalytical methods for the quantification of therapeutic monoclonal antibodies and their application in clinical pharmacokinetic studies. Hum Antibodies 2009;18:47-73
   PubMedGoogle Scholar
• Dawes ML, Gu H, Wang J, et al. Development of a validated liquid chromatography tandem mass spectrometry assay for a PEGylated adnectin in cynomolgus monkey plasma using protein precipitation and trypsin digestion. J Chromatogr B 2013;934:1-7
   PubMedGoogle Scholar
• de Dios K, Manibusan A, Marsden R, Pinkstaff J. Comparison of bioanalytical methods for the quantitation of PEGylated human insulin. J Immunol Methods 2013;396:1-7
   PubMed Web of Science ®Google Scholar
• Delinsky DC, Hill KT. Quantitation of the large polypeptide glucagon by protein precipitation and LC/MS. Biomed Chromatogr 2004;18:700-5
   PubMedGoogle Scholar
• Dillen L, Cools W, Vereyken L. Comparison of triple quadrupole and high-resolution TOF-MS for quantification of peptides. Bioanalysis 2012;4:565-79
   PubMed Web of Science ®Google Scholar
• Dufield DR, Radabaugh MR. Online immunoaffinity LC/MS/MS. A general method to increase sensitivity and specificity: How do you do it and what do you need? Methods 2012;56:236-45
   PubMed Web of Science ®Google Scholar
• Ewles M, Goodwin L. Bioanalytical approaches to analyzing peptides and proteins by LC--MS/MS. Bioanalysis 2011;3:1379-97
   PubMed Web of Science ®Google Scholar
• Ezan E, Bitsch F. Critical comparison of MS and immunoassays for the bioanalysis of therapeutic antibodies. Bioanalysis 2009;1(8):1375-88
   PubMed Web of Science ®Google Scholar
• Ezan E, Dubois M, Becher F. Bioanalysis of recombinant proteins and antibodies by mass spectrometry. Analyst 2009;134:825-34
   PubMed Web of Science ®Google Scholar
• Fernández Ocaña M, James IT, Kabir M, et al. Clinical pharmacokinetic assessment of an anti-MAdCAM monoclonal antibody therapeutic by LC-MS/MS. Anal Chem 2012;84:5959-67
   PubMedGoogle Scholar
• Furlong MT, Ouyang Z, Wu S, et al. A universal surrogate peptide to enable LC-MS/MS bioanalysis of a diversity of human monoclonal antibody and human Fc-fusion protein drug candidates in pre-clinical animal studies. Biomed Chromatogr 2012;26:1024-32
   PubMed Web of Science ®Google Scholar
• Furlong MT, Titsch C, Xu W, et al. An exploratory universal LC-MS/MS assay for bioanalysis of hinge region-stabilized human IgG4 mAbs in clinical studies. Bioanalysis 2014;6:1747-58
   PubMed Web of Science ®Google Scholar
• Furlong MT, Zhao S, Mylott W, Jenkins R. Dual universal peptide approach to bioanalysis of human monoclonal antibody protein drug candidates in animal studies. Bioanalysis 2013;5:1363-76
   PubMed Web of Science ®Google Scholar
• Halquist MS, Karnes HT. Quantification of Alefacept, an immunosuppressive fusion protein in human plasma using a protein analogue internal standard, trypsin cleaved signature peptides and liquid chromatography tandem mass spectrometry. J Chromatogr B 2011;879:789-98
   PubMed Web of Science ®Google Scholar
• Heinig K, Wirz T, Schick E, Guenzi A. Bioanalysis of therapeutic peptides: differentiating between total and anti-drug antibody bound drug using liquid chromatography-tandem mass spectrometry quantitation. J Chromat A 2013;1316:69-77
   PubMedGoogle Scholar
• Heudi O, Barteau S, Zimmer D, et al. Towards absolute quantification of therapeutic monoclonal antibody in serum by LC-MS/MS using isotope-labeled antibody standard and protein cleavage isotope dilution mass spectrometry. Anal Chem 2008;80:4200-7
   PubMed Web of Science ®Google Scholar
• Hoofnagle AN, Becker JO, Wener MH, Heinecke JW. Quantification of thyroglobulin, a low-abundance serum protein, by immunoaffinity peptide enrichment and tandem mass spectrometry. Clin Chem 2008;54(11):1796-804
   PubMed Web of Science ®Google Scholar
• Hoofnagle AN, Wener MH. The fundamental flaws of immunoassays and potential solutions using tandem mass spectrometry. J Immunol Methods 2009;347:3-11
   PubMed Web of Science ®Google Scholar
• Ji C, Sadagopan N, Zhang Y, Lepsy C. A universal strategy for development of a method for absolute quantification of therapeutic monoclonal antibodies in biological matrices using differential dimethyl labeling coupled with ultra performance liquid chromatography-tandem mass spectrometry. Anal Chem 2009;81:9321-8
   PubMedGoogle Scholar
• Ji QC, Rodila R, Gage EM, El-Shourbagy TA. A strategy of plasma protein quantitation by selective reaction monitoring of an intact protein. Anal Chem 2003;75:7008-14
   PubMed Web of Science ®Google Scholar
• Jiang H, Zeng J, Titsch C, et al. Fully validated LC-MS/MS assay for the simultaneous quantitation of coadministered therapeutic antibodies in cynomolgus monkey serum. Anal Chem 2013;85:9859-67
   PubMed Web of Science ®Google Scholar
• Kirsch S, Widart J, Louette J, et al. Development of an absolute quantification method targeting growth hormone biomarkers using liquid chromatography coupled to isotope dilution mass spectrometry. J Chromat A 2007;1153:300-6
   PubMed Web of Science ®Google Scholar
• Kleemann GR, Beierle J, Nichols AC, et al. Characterization of IgG1 immunoglobulins and peptide-Fc fusion proteins by limited proteolysis in conjunction with LC-MS. Anal Chem 2008;80:2001-9
   Google Scholar
• Knutsson M, Schmidt R, Timmerman P. LC-MS/MS of large molecules in a regulated bioanalytical environment - which acceptance criteria to apply? Bioanalysis 2013;5:2211-14
   PubMedGoogle Scholar
• Kumar V, Barnidge DR, Chen LS, et al. Quantification of serum 1-84 parathyroid hormone in patients with hyperparathyroidism by immunocapture in situ digestion liquid chromatography-tandem mass spectrometry. Clin Chem 2010;56:306-13
   PubMed Web of Science ®Google Scholar
• Kushnir MM, Rockwood AL, Roberts WL, et al. Measurement of thyroglobulin by liquid chromatography-tandem mass spectrometry in serum and plasma in the presence of antithyroglobulin autoantibodies. Clin Chem 2013;59:982-90
   PubMed Web of Science ®Google Scholar
• Lee JW, Kelley M, King LE, et al. White paper bioanalytical approaches to quantify “total” and “free” therapeutic antibodies and their targets : technical challenges and PK/ PD applications over the course of drug development. AAPS J 2011;13:99-110
   PubMed Web of Science ®Google Scholar
• Li F, Fast D, Michael S. Absolute quantitation of protein therapeutics in biological matrices by enzymatic digestion and LC-MS. Bioanalysis 2011;3:2459-80
   PubMed Web of Science ®Google Scholar
• Li H, Ortiz R, Tran L, et al. General LC-MS/MS method approach to quantify therapeutic monoclonal antibodies using a common whole antibody internal standard with application to preclinical studies. Anal Chem 2012;84:1267-73
   PubMed Web of Science ®Google Scholar
• Li H, Ortiz R, Tran LTB, Salimi-Moosavi H. Simultaneous analysis of multiple monoclonal antibody biotherapeutics by LC-MS/MS method in rat plasma following cassette-dosing. AAPS J 2013;15:1267-73
   Google Scholar
• Lin M, Lassman ME, Weiner R, Laterza OF. Development and fit-for-purpose validation of a LC-MS/MS assay for fibrinogen peptide A quantitation in human plasma. Bioanalysis 2014;6:1759-66
   PubMedGoogle Scholar
• Liu H, Manuilov AV, Chumsae C, et al. Quantitation of a recombinant monoclonal antibody in monkey serum by liquid chromatography-mass spectrometry. Anal Biochem 2011;414:147-53
   PubMed Web of Science ®Google Scholar
• Lu Q, Zheng X, McIntosh T, et al. Development of different analysis platforms with LC-MS for pharmacokinetic studies of protein drugs. Anal Chem 2009;81:8715-23
   PubMedGoogle Scholar
• Mekhssian K, Mess J-N, Garofolo F. Application of high-resolution MS in the quantification of a therapeutic monoclonal antibody in human plasma. Bioanalysis 2014;6:1767-79
   PubMed Web of Science ®Google Scholar
• Nelson RW, Nedelkov D, Tubbs KA, Kiernan UA. Quantitative Mass Spectrometric Immunoassay of Insulin Like Growth Factor 1 research articles. J Proteome Res 2004;3:851-5
   PubMed Web of Science ®Google Scholar
• Nouri-Nigjeh E, Zhang M, Ji T, Yu H. Effects of Calibration Approaches on the Accuracy for LC–MS Targeted Quantification of Therapeutic Protein. Anal Chem 2014;86:3575-84
   PubMedGoogle Scholar
• Nowatzke WL, Rogers K, Wells E, et al. Unique challenges of providing bioanalytical support for biological therapeutic pharmacokinetic programs. Bioanalysis 2011;3:509-21
   Google Scholar
• Onami I, Ayabe M, Murao N, Ishigai M. A versatile method for protein-based antigen bioanalysis in non-clinical pharmacokinetics studies of a human monoclonal antibody drug by an immunoaffinity liquid chromatography-tandem mass spectrometry. J Chromat A 2014;1334:64-71
   PubMedGoogle Scholar
• Pan S, Aebersold R, Chen R. Mass spectrometry based targeted protein quantification: methods and applications. J Proteome Res 2008;8:787-97
   Web of Science ®Google Scholar
• Rauh M. LC-MS/MS for protein and peptide quantification in clinical chemistry. J Chromatogr B 2012;883-4
   Web of Science ®Google Scholar
• Sandra K, Mortier K, Jorge L, et al. LC-MS/MS quantification of next-generation biotherapeutics: a case study for an IgE binding Nanobody in cynomolgus monkey plasma. Bioanalysis 2014;6:1201-13
   PubMed Web of Science ®Google Scholar
• van de Merbel NC, Bronsema KJ, Nemansky M. Protein quantification using LC-MS: can it make a difference? Bioanalysis 2012;4:2113-16
   PubMedGoogle Scholar
• van den Broek I, Sparidans RW, Schellens JH, Beijnen JH. Quantitative bioanalysis of peptides by liquid chromatography coupled to (tandem) mass spectrometry. J Chromatogr B 2008;872:1-22
   PubMed Web of Science ®Google Scholar
• Vazvaei F, Duggan JX. Validation of LC-MS/MS bioanalytical methods for protein therapeutics. Bioanalysis 2014;6:1739-42
   PubMedGoogle Scholar
• Wang Y, Qu Y, Bellows CL, et al. Simultaneous quantification of davalintide, a novel amylin-mimetic peptide, and its active metabolite in beagle and rat plasma by online SPE and LC-MS/MS. Bioanalysis 2012;4:2141-52
   PubMedGoogle Scholar
• Whiteaker JR, Zhao L. An automated and multiplexed method for high throughput peptide immunoaffinity enrichment and multiple reaction monitoring mass spectrometry-based quantification. Mol Cell Proteomics 2010;9:184-96
   PubMed Web of Science ®Google Scholar
• Wilffert D, Reis CR, Hermans J, et al. Antibody-free LC-MS/MS quantification of rhTRAIL in human and mouse serum. Anal Chem 2013;85:10754-60
   PubMedGoogle Scholar
• Wright K, Dufield D. Minimalistic sample preparation strategies for LC-MS quantification of large molecule biopharmaceuticals: a case study highlighting alpha-1 antitrypsin protein. Bioanalysis 2014;6:1813-25
   PubMed Web of Science ®Google Scholar
• Xu K, Liu L, Maia M, et al. A multiplexed hybrid LC-MS/MS pharmacokinetic assay to measure two co-administered monoclonal antibodies in a clinical study. Bioanalysis 2014;6:1781-94
   PubMed Web of Science ®Google Scholar
• Xu Y, Mehl JT, Bakhtiar R, Woolf EJ. Immunoaffinity purification using anti-PEG antibody followed by two-dimensional liquid chromatography/tandem mass spectrometry for the quantification of a PEGylated therapeutic peptide in human plasma. Anal Chem 2010;82:6877-86
   PubMed Web of Science ®Google Scholar
• Yang Z, Hayes M, Fang X, et al. LC-MS/MS approach for quantification of therapeutic proteins in plasma using a protein internal standard and 2D-solid-phase extraction cleanup. Anal Chem 2007;79:9294-301
   PubMed Web of Science ®Google Scholar
• Yang Z, Ke J, Hayes M, et al. A sensitive and high-throughput LC-MS/MS method for the quantification of pegylated-interferon-alpha2a in human serum using monolithic C18 solid phase extraction for enrichment. J Chromatogr B 2009;877:1737-42
   PubMed Web of Science ®Google Scholar
• Yuan L, Aubry A-F, Arnold ME, Ji QC. Systematic investigation of orthogonal SPE sample preparation for the LC-MS/MS bioanalysis of a monoclonal antibody after pellet digestion. Bioanalysis 2013;5:2379-91
   PubMedGoogle Scholar
• Zhang Q, Spellman DS, Song Y, et al. Generic automated method for liquid chromatography-multiple reaction monitoring mass spectrometry based monoclonal antibody quantitation for preclinical pharmacokinetic studies. Anal Chem 2014;86:8776-84
   PubMed Web of Science ®Google Scholar
• Zheng J, Mehl J, Zhu Y, et al. Application and challenges in using LC-MS assays for absolute quantitative analysis of therapeutic proteins in drug discovery. Bioanalysis 2014;6:859-79
   PubMed Web of Science ®Google Scholar
• Bischoff R, Bronsema KJ, van de Merbel NC. Analysis of biopharmaceutical proteins in biological matrices by LC-MS/MS I. sample preparation. TrAC Trends Anal Chem 2013;48:41-51
   Google Scholar
• Hopfgartner G, Lesur A, Varesio E. Analysis of biopharmaceutical proteins in biological matrices by LC-MS/MS II. LC-MS/MS analysis. TrAC Trends Anal Chem 2013;48:52-61
   Google Scholar
• Jungblut PR, Holzhutter HG, Apweiler R, Schluter H. The speciation of the proteome. Chem Cent J 2008;2:16
   PubMed Web of Science ®Google Scholar
• Schluter H, Apweiler R, Holzhutter HG, Jungblut PR. Finding one’s way in proteomics: a protein species nomenclature. Chem Cent J 2009;3:11
   PubMedGoogle Scholar
• Foster MW, Thompson JW, Ledford JG, et al. Identification and Quantitation of Coding Variants and Isoforms of Pulmonary Surfactant Protein A. J Proteome Res 2014;13:3722-32
   PubMedGoogle Scholar
• Lisitsa A, Moshkovskii S, Chernobrovkin A, et al. Profiling proteoforms: Promising follow-up of proteomics for biomarker discovery. Expert Rev Proteomics 2014;11:121-9
   PubMed Web of Science ®Google Scholar
• Yang Y, Barendregt A, Kamerling JP, Heck AJ. Analyzing protein micro-heterogeneity in chicken ovalbumin by high-resolution native mass spectrometry exposes qualitatively and semi-quantitatively 59 proteoforms. Anal Chem 2013;85:12037-45
   PubMed Web of Science ®Google Scholar
• Smith LM, Kelleher NL. Proteoform: a single term describing protein complexity. Nat Methods 2013;10:186-7
   PubMed Web of Science ®Google Scholar
• Vegvari A, Sjodin K, Rezeli M, et al. Identification of a Novel Proteoform of Prostate Specific Antigen (SNP-L132I) in Clinical Samples by Multiple Reaction Monitoring. Mol Cell Proteomics 2013;12:2761-73
   PubMed Web of Science ®Google Scholar
• Liu X, Hengel S, Wu S, et al. Identification of Ultramodified Proteins Using Top-Down Tandem Mass Spectra. J Proteome Res 2013;12(12):5830-8
   PubMed Web of Science ®Google Scholar
• Steel LF, Haab BB, Hanash SM. Methods of comparative proteomic profiling for disease diagnostics. J Chromatogr B 2005;815:275-84
   PubMed Web of Science ®Google Scholar
• Huang X, Wei Y, Li L, et al. Serum proteomics study of the squamous cell carcinoma antigen 1 in tongue cancer. Oral Oncol 2005;42:26-31
   PubMedGoogle Scholar
• Yoo BS, Regnier FE. Proteomic analysis of carbonylated proteins in two-dimensional gel electrophoresis using avidin-fluorescein affinity staining. Electrophoresis 2004;25(9):1334-41
   PubMedGoogle Scholar
• Terry DE, Desiderio DM. Between-gel reproducibility of the human cerebrospinal fluid proteome. Proteomics 2003;3:1962-79
   PubMedGoogle Scholar
• Garfin DE. Two-dimensional gel electrophoresis: an overview. TrAC Trends Anal Chem 2003;22:263-72
   Web of Science ®Google Scholar
• Caldini A, Moneti G, Fanelli A, et al. Epoetin alpha, epoetin beta and darbepoetin alfa: two-dimensional gel electrophoresis isoforms characterization and mass spectrometry analysis. Proteomics 2003;3:937-41
   PubMed Web of Science ®Google Scholar
• Beranova-Giorgianni S. Proteome analysis by two-dimensional gel electrophoresis and mass spectrometry: strengths and limitations. TrAC Trends Anal Chem 2003;22:273-81
   Web of Science ®Google Scholar
• Galeva N, Altermann M. Comparison of one-dimensional and two-dimensional gel electrophoresis as a separation tool for proteomic analysis of rat liver microsomes: Cytochromes P450 and other membrane proteins. Proteomics 2002;2:713-22
   PubMed Web of Science ®Google Scholar
• Pan T, Colucci M, Wong BS, et al. Novel Differences between Two Human Prion Strains Revealed by Two-dimensional Gel Electrophoresis. J Biol Chem 2001;276:37284-8
   PubMed Web of Science ®Google Scholar
• Gygi SP, Corthals GL, Zhang Y, et al. Evaluation of two-dimensional gel electrophoresis-based proteome analysis technology. Proc Nat Acad Sci 2000;97:9390-5
   PubMed Web of Science ®Google Scholar
• Cordwell SJ, Nouwens AS, Verrills NM, et al. Subproteomics based upon protein cellular location and relative solubilities in conjunction with composite two-dimensional electrophoresis gels. Electrophoresis 2000;21:1094-103
   PubMed Web of Science ®Google Scholar
• Celis JE, Gromov P. 2D protein electrophoresis: can it be perfected? Curr Opin Biotechnol 1999;10:16-21
   PubMed Web of Science ®Google Scholar
• Wilkins MR, Gasteiger E, Sanchez JC, et al. Two-dimensional gel electrophoresis for proteome projects: The effects of protein hydrophobicity and copy number. Electrophoresis 1998;19:1501-5
   PubMed Web of Science ®Google Scholar
• Rabilloud T. Use of thiourea to increase the solubility of membrane proteins in two-dimensional electrophoresis. Electrophoresis 1998;19:758-60
   PubMed Web of Science ®Google Scholar
• Packer NH, Lawson MA, Jardine DR, et al. Analyzing glycoproteins separated by two-dimensional gel electrophoresis. Electrophoresis 1998;19:981-8
   PubMedGoogle Scholar
• Fountoulakis M, Takacs B, Langen H. Two-dimensional map of basic proteins of Haemophilus influenzae. Electrophoresis 1998;19:761-6
   PubMedGoogle Scholar
• Rosenfeld J, Capdevielle J, Guillemot JC, Ferrara P. In-gel digestion of proteins for internal sequence analysis after one- or two-dimensional gel electrophoresis. Anal Biochem 1992;203:173-9
   PubMed Web of Science ®Google Scholar
• Schupbach J, Ammann RW, Freiburghaus AU. A universal method for two-dimensional polyacrylamide gel electrophoresis of membrane proteins using isoelectric focusing on immobilized pH gradients in the first dimension. Anal Biochem 1991;196:337-43
   PubMedGoogle Scholar
• Hochstrasser DF, Harrington MG, Hochstrasser AC, et al. Methods for increasing the resolution of two-dimensional protein electrophoresis. Anal Biochem 1988;173:424-35
   PubMed Web of Science ®Google Scholar
• Silva JC, Gorenstein MV, Li GZ, et al. Absolute quantification of proteins by LCMSE: a virtue of parallel ms acquisition. Mol Cell Proteom 2006;5:144-56
   PubMed Web of Science ®Google Scholar
• Fabre B, Lambour T, Bouyssié D, et al. Comparison of label-free quantification methods for the determination of protein complexes subunits stoichiometry. EuPA Open Proteomics 2014;4:82-6
   Google Scholar
• Krey JF, Wilmarth PA, Shin JB, et al. Accurate label-free protein quantitation with high- and low-resolution mass spectrometers. J Proteome Res 2014;13:1034-44
   PubMed Web of Science ®Google Scholar
• Ahrne E, Molzahn L, Glatter T, Schmidt A. Critical assessment of proteome-wide label-free absolute abundance estimation strategies. Proteomics 2013;13:2567-78
   PubMed Web of Science ®Google Scholar
• Walsh CT. Posttranslational modifications of proteins: expanding nature´s inventory. Rober Comp Publish 2006;45(7):1020
   Google Scholar
• Bischoff R, Schlüter H. Amino acids: Chemistry, functionality and selected non-enzymatic post-translational modifications. J Proteomics 2012;75:2275-96
   PubMed Web of Science ®Google Scholar
• Walsh CT, Garneau-Tsodikova S, Gatto J. Protein posttranslational modifications: the chemistry of proteome diversifications. Angew Chem Int Ed Engl 2005;44:7342-72
   PubMed Web of Science ®Google Scholar
• Wang S, Kaltashov IA. An 18O-labeling assisted LC/MS method for assignment of aspartyl/isoaspartyl products from asn deamidation and asp isomerization in proteins. Anal Chem 2013;85:6446-52
   PubMedGoogle Scholar
• Shimura K, Hoshino M, Kamiya K, et al. Estimation of the deamidation rates of major deamidation sites in a fab fragment of mouse IgG1-k by capillary isoelectric focusing of mutated fab fragments. Anal Chem 2013;85:1705-10
   PubMedGoogle Scholar
• Nepomuceno AI, Gibson RJ, Randall SM, Muddiman DC. Accurate identification of deamidated peptides in global proteomics using a quadrupole orbitrap mass spectrometer. J Proteome Res 2013;13:777-85
   PubMedGoogle Scholar
• Palmisano G, Melo-Braga MN, Engholm-Keller K, et al. Chemical deamidation: a common pitfall in large-scale n-linked glycoproteomic mass spectrometry-based analyses. J Proteome Res 2012;11:1949-57
   PubMed Web of Science ®Google Scholar
• Du Y, Wang F, May K, et al. Determination of deamidation artifacts introduced by sample preparation using 18o-labeling and tandem mass spectrometry analysis. Anal Chem 2012;84:6355-60
   PubMedGoogle Scholar
• Wang S, Bobst CE, Kaltashov IA. Pitfalls in protein quantitation using acid-catalyzed o18 labeling: hydrolysis-driven deamidation. Anal Chem 2011;83(18):7227-32
   PubMed Web of Science ®Google Scholar
• Liu M, Cheetham J, Cauchon N, et al. Protein isoaspartate methyltransferase-mediated 18o-labeling of isoaspartic acid for mass spectrometry analysis. Anal Chem 2011;84:1056-62
   PubMedGoogle Scholar
• Hao P, Ren Y, Alpert AJ, Sze SK. Detection, evaluation and minimization of nonenzymatic deamidation in proteomic sample preparation. Mol Cell Proteomics 2011;10:10
   Google Scholar
• Zhang X, Hojrup P. Cyclization of the N-Terminal X-Asn-Gly Motif during Sample Preparation for Bottom-Up Proteomics. Anal Chem 2010;82:8680-5
   PubMedGoogle Scholar
• Yang H, Zubarev RA. Mass spectrometric analysis of asparagine deamidation and aspartate isomerization in polypeptides. Electrophoresis 2010;31:1764-72
   Google Scholar
• Ni W, Dai S, Karger BL, Zhou ZS. Analysis of isoaspartic acid by selective proteolysis with asp-N and electron transfer dissociation mass spectrometry. Anal Chem 2010;82:7485-91
   PubMedGoogle Scholar
• Vlasak J, Bussat MC, Wang S, et al. Identification and characterization of asparagine deamidation in the light chain CDR1 of a humanized IgG1 antibody. Anal Biochem 2009;392:145-54
   PubMed Web of Science ®Google Scholar
• Sharma KK, Santhoshkumar P. Lens aging: effects of crystallins. Bio Biophy Acta 2009;1790:1095-108
   PubMed Web of Science ®Google Scholar
• Liu YD, van Enk JZ, Flynn GC. Human antibody Fc deamidation in vivo. Biologicals 2009;37:313-22
   PubMed Web of Science ®Google Scholar
• Dasari S, Wilmarth PA, Reddy AP, et al. Quantification of isotopically overlapping deamidated and 18o-labeled peptides using isotopic envelope mixture modeling. J Proteome Res 2009;8:1263-70
   PubMedGoogle Scholar
• Liu H, Gaza-Bulseco G, Faldu D, et al. Heterogeneity of monoclonal antibodies. J Pharm Sci 2008;97:2426-47
   PubMed Web of Science ®Google Scholar
• Jenkins N, Murphy L, Tyther R. Post-translational modifications of recombinant proteins: significance for biopharmaceuticals. Mol Biotechnol 2008;39:113-18
   PubMed Web of Science ®Google Scholar
• Gaza-Bulseco G, Li B, Bulseco A, Liu H. Method to differentiate asn deamidation that occurred prior to and during sample preparation of a monoclonal antibody. Anal Chem 2008;80:9491-8
   Google Scholar
• Krokhin OV, Antonovici M, Ens W, et al. Deamidation of -asn-gly- sequences during sample preparation for proteomics: consequences for MALDI and HPLC-MALDI analysis. Anal Chem 2006;78:6645-50
   PubMed Web of Science ®Google Scholar
• Hipkiss AR. Accumulation of altered proteins and ageing: causes and effects. Exp Gerontol 2006;41:464-73
   PubMed Web of Science ®Google Scholar
• Gupta R, Srivastava OP. Deamidation affects structural and functional properties of human {alpha}A-crystallin and its oligomerization with {alpha}B-Crystallin. J Biol Chem 2004;279:44258-69
   PubMed Web of Science ®Google Scholar
• Robinson NE. Protein deamidation. Proc Nat Acad Sci 2002;99:5283-8
   PubMed Web of Science ®Google Scholar
• Robinson NE, Robinson AB. Prediction of protein deamidation rates from primary and three-dimensional structure. Proc Nat Acad Sci 2001;98:4367-72
   PubMed Web of Science ®Google Scholar
• Harris RJ, Kabakoff B, Macchi FD, et al. Identification of multiple sources of charge heterogeneity in a recombinant antibody. J Chromatogr B 2001;752:233-45
   PubMed Web of Science ®Google Scholar
• Carlson AD, Riggin RM. Development of improved high-performance liquid chromatography conditions for nonisotopic detection of isoaspartic acid to determine the extent of protein deamidation. Anal Biochem 2000;278:150-5
   PubMedGoogle Scholar
• Hsu YR, Chang WC, Mendiaz EA, et al. Selective deamidation of recombinant human stem cell factor during in vitro aging: Isolation and characterization of the aspartyl and isoaspartyl homodimers and heterodimers. Biochemistry 1998;37:2251-62
   PubMedGoogle Scholar
• Bischoff R, Kolbe HV. Deamidation of asparagine and glutamine residues in proteins and peptides: structural determinants and analytical methodology. J Chromatogr B 1994;662:261-78
   PubMed Web of Science ®Google Scholar
• Bischoff R, Lepage P, Jaquinod M, et al. Sequence-specific deamidation: isolation and biochemical characterization of succinimide intermediates of recombinant hirudin. Biochemistry 1993;32:725-34
   PubMedGoogle Scholar
• Martinez-Morillo E, Nielsen HM, Batruch I, et al. Assessment of peptide chemical modifications on the development of an accurate and precise multiplex selected reaction monitoring assay for apolipoprotein e isoforms. J Proteome Res 2014;13:1077-87
   PubMed Web of Science ®Google Scholar
• Liu H, Ponniah G, Neill A, et al. Accurate Determination of Protein Methionine Oxidation by Stable Isotope Labeling and LC-MS Analysis. Anal Chem 2013;85:11705-9
   PubMed Web of Science ®Google Scholar
• Spickett CM, Pitt AR. Protein oxidation: role in signalling and detection by mass spectrometry. Amino Acids 2012;42:5-21
   PubMed Web of Science ®Google Scholar
• Ghesquiere B, Jonckheere V, Colaert N, et al. Redox Proteomics of Protein-bound Methionine Oxidation. Mol Cell Proteomics 2011;10:10
   Google Scholar
• Lancellotti S, De FV, Pozzi N, et al. Formation of methionine sulfoxide by peroxynitrite at position 1606 of von Willebrand factor inhibits its cleavage by ADAMTS-13: A new prothrombotic mechanism in diseases associated with oxidative stress. Free Radic Biol Med 2010;48:446-56
   PubMedGoogle Scholar
• Zhang H, Zielonka J, Sikora A, et al. The effect of neighboring methionine residue on tyrosine nitration and oxidation in peptides treated with MPO, H2O2, and NO2- or peroxynitrite and bicarbonate: Role of intramolecular electron transfer mechanism? Arch Biochem Biophys 2009;484:134-45
   PubMed Web of Science ®Google Scholar
• Rebrin I, Bregere C, Gallaher TK, Sohal RS. Detection and characterization of peroxynitrite-induced modifications of tyrosine, tryptophan, and methionine residues by tandem mass spectrometry. Methods Enzymol 2008;441:283-94
   PubMedGoogle Scholar
• Shao B, Belaaouaj A, Verlinde CL, et al. Methionine sulfoxide and proteolytic cleavage contribute to the inactivation of cathepsin G by hypochlorous acid: an oxidative mechanism for regulation of erine proteinases by myeloperoxidase. J Biol Chem 2005;280:29311-21
   PubMedGoogle Scholar
• Harris RJ. Heterogeneity of recombinant antibodies: linking structure to function. Dev Biol (Basel) 2005;122:117-27
   PubMedGoogle Scholar
• Leichert LI, Jakob U. Protein thiol modifications visualized in vivo. PLoS Biol 2004;2:e333
   PubMed Web of Science ®Google Scholar
• Guan Z, Yates NA, Bakhtiar R. Detection and characterization of methionine oxidation in peptides by collision-induced dissociation and electron capture dissociation. J Am Soc Mass Spectrom 2003;14:605-13
   Google Scholar
• Kanayama A, Inoue JI, Sugita-Konishi Y, et al. Oxidation of ikappa balpha at methionine 45 is one cause of taurine chloramine-induced inhibition of NF-kappa B activation. J Biol Chem 2002;277:24049-56
   PubMed Web of Science ®Google Scholar
• Griffiths SW, King J, Cooney CL. The reactivity and oxidation pathway of cysteine 232 in recombinant human alpha 1-antitrypsin. J Biol Chem 2002;277:25486-92
   PubMed Web of Science ®Google Scholar
• Griffiths SW, Cooney CL. Development of a peptide mapping procedure to identify and quantify methionine oxidation in recombinant human [alpha]1-antitrypsin. J Chromat A 2002;942:133-43
   PubMed Web of Science ®Google Scholar
• Stadtman ER. Protein oxidation in aging and age-related diseases. Ann N Y Acad Sci 2001;928:22-38
   PubMed Web of Science ®Google Scholar
• Davis DA, Newcomb FM, Moskovitz J, et al. HIV-2 protease is inactivated after oxidation at the dimer interface and activity can be partly restored with methionine sulphoxide reductase. Biochem J 2000;2:305-11
   Google Scholar
• Jiang XSJBAEC. Identification of a MS-MS fragment diagnostic for methionine sulfoxide. J Mass Spectrom 1996;31:1309-10
   Google Scholar
• Vogt W. Oxidation of methionyl residues in proteins: tools, targets, and reversal. Free Radic Biol Med 1995;18:93-105
   PubMed Web of Science ®Google Scholar
• Li Y, Polozova A, Gruia F, Feng J. Characterization of the Degradation Products of a Color-Changed Monoclonal Antibody: Tryptophan-Derived Chromophores. Anal Chem 2014;86:6850-7
   Google Scholar
• Amano M, Kobayashi N, Yabuta M, et al. Detection of Histidine Oxidation in a Monoclonal Immunoglobulin Gamma (IgG) 1 Antibody. Anal Chem 2014;86:7536-43
   PubMed Web of Science ®Google Scholar
• Roeser J, Bischoff R, Bruins AP, Permentier HP. Oxidative protein labeling in mass spectrometry-based proteomics. Anal Bioanal Chem 2010;397:3441-55
   PubMed Web of Science ®Google Scholar
• Perdivara I, Deterding LJ, Przybylski M, Tomer KB. Mass spectrometric identification of oxidative modifications of tryptophan residues in proteins: chemical artifact or post-translational modification? J Am Soc Mass Spectrom 2010;21:1114-17
   PubMed Web of Science ®Google Scholar
• Bregere C, Rebrin I, Sohal RS. Detection and characterization of in vivo nitration and oxidation of tryptophan residues in proteins. Methods Enzymol 2008;441:339-49
   PubMedGoogle Scholar
• Yamakura F, Ikeda K. Modification of tryptophan and tryptophan residues in proteins by reactive nitrogen species. Nitric Oxide 2006;14:152-61
   PubMed Web of Science ®Google Scholar
• Yamakura F, Matsumoto T, Ikeda K, et al. Nitrated and oxidized products of a single tryptophan residue in human Cu,Zn-superoxide dismutase treated with either peroxynitrite-carbon dioxide or myeloperoxidase-hydrogen peroxide-nitrite. J Biochem 2005;138:57-69
   PubMedGoogle Scholar
• Fu X, Kao JLF, Bergt C, et al. Oxidative Cross-linking of Tryptophan to Glycine Restrains Matrix Metalloproteinase Activity: specific structural motifs control protein oxidation. J Biol Chem 2004;279:6209-12
   PubMed Web of Science ®Google Scholar
• Taylor SW, Fahy E, Murray J, et al. Oxidative post-translational modification of tryptophan residues in cardiac mitochondrial proteins. J Biol Chem 2003;278:19587-90
   PubMed Web of Science ®Google Scholar
• Hambly DM, Gross ML. Cold Chemical Oxidation of Proteins. Anal Chem 2009;81:7235-42
   PubMedGoogle Scholar
• Zhan X, Wang X, Desiderio DM. Mass spectrometry analysis of nitrotyrosine-containing proteins. Mass Spectrom Rev 2013. [Epub ahead of print]
   Google Scholar
• Radi R. Protein tyrosine nitration: Biochemical mechanisms and structural basis of functional effects. Acc Chem Res 2013;46:550-9
   PubMed Web of Science ®Google Scholar
• Evans AR, Robinson RA. Proteomics quantification of protein nitration. Rev Analyt Chem 2013;32:173-87
   Google Scholar
• Diaz-Moreno I, Garcia-Heredia JM, Gonzalez-Arzola K, et al. Recent methodological advances in the analysis of protein tyrosine nitration. ChemPhysChem 2013;14:3095-102
   PubMedGoogle Scholar
• Butterfield DA, Dalle-Donne I. Redox proteomics. Antioxid Redox Signal 2012;17:1487-9
   PubMed Web of Science ®Google Scholar
• Nuriel T, Hansler A, Gross SS. Protein nitrotryptophan: Formation, significance and identification. J Proteomics 2011;74:2300-12
   PubMed Web of Science ®Google Scholar
• Aslan M, Dogan S. Proteomic detection of nitroproteins as potential biomarkers for cardiovascular disease. J Proteomics 2011;74:2274-88
   PubMedGoogle Scholar
• Abello N, Kerstjens HA, Postma DS, Bischoff R. Protein Tyrosine Nitration: Selectivity, physicochemical and biological consequences, denitration and proteomics methods for the identification of tyrosine-nitrated proteins. J Proteome Res 2009;8:3222-38
   PubMed Web of Science ®Google Scholar
• Yeo WS, Lee SJ, Lee JR, Kim KP. Nitrosative protein tyrosine modifications: biochemistry and functional significance. BMB Reports 2008;41:194-203
   PubMed Web of Science ®Google Scholar
• Souza JM, Peluffo G, Radi R. Protein tyrosine nitration-Functional alteration or just a biomarker? Free Radic Biol Med 2008;45:357-66
   PubMed Web of Science ®Google Scholar
• Salzano AM, D’Ambrosio C, Scaloni A. Mass spectrometric characterization of proteins modified by nitric oxide-derived species. Methods Enzymol 2008;440:3-15
   PubMedGoogle Scholar
• Nuriel T, Deeb RS, Hajjar DP, Gross SS. Protein 3-nitrotyrosine in complex biological samples: quantification by high-pressure liquid chromatography/electrochemical detection and emergence of proteomic approaches for unbiased identification of modification sites. Methods Enzymol 2008;441:1-17
   PubMedGoogle Scholar
• Monteiro HP, Arai RJ, Travassos LR. Protein tyrosine phosphorylation and protein tyrosine nitration in redox signaling. Antioxid Redox Signal 2008;10:843-89
   PubMed Web of Science ®Google Scholar
• Ischiropoulos H. Protein tyrosine nitration--An update. Arch Biochem Biophys 2008;484:117-21
   PubMed Web of Science ®Google Scholar
• Butterfield DA, Sultana R. Identification of 3-nitrotyrosine-modified brain proteins by redox proteomics. Methods Enzymol 2008;440:295-308
   Google Scholar
• Butt YK, Lo SC. Detecting nitrated proteins by proteomic technologies. Methods Enzymol 2008;440:17-31
   PubMedGoogle Scholar
• Peluffo G, Radi R. Biochemistry of protein tyrosine nitration in cardiovascular pathology. Cardiovasc Res 2007;75:291-302
   PubMed Web of Science ®Google Scholar
• Bartesaghi S, Ferrer-Sueta G, Peluffo G, et al. Protein tyrosine nitration in hydrophilic and hydrophobic environments. Amino Acids 2007;32:501-15
   PubMed Web of Science ®Google Scholar
• Ohmori H, Kanayama N. Immunogenicity of an inflammation-associated product, tyrosine nitrated self-proteins. Autoimmun Rev 2005;4:224-9
   PubMed Web of Science ®Google Scholar
• Ischiropoulos H. Biological selectivity and functional aspects of protein tyrosine nitration. Biochem Biophys Res Commun 2003;305:776-83
   PubMed Web of Science ®Google Scholar
• Ghezzi P, Bonetto V. Redox proteomics: identification of oxidatively modified proteins. Proteomics 2003;3:1145-53
   PubMed Web of Science ®Google Scholar
• Alvarez B, Radi R. Peroxynitrite reactivity with amino acids and proteins. Amino Acids 2003;25:295-311
   PubMed Web of Science ®Google Scholar
• Turko IV, Murad F. Protein nitration in cardiovascular diseases. Pharmacol Rev 2002;54(4):619-34
   PubMedGoogle Scholar
• Sabetkar M, Low SY, Naseem KM, Bruckdorfer KR. The nitration of proteins in platelets: significance in platelet function. Free Radic Biol Med 2002;33:728-34
   PubMed Web of Science ®Google Scholar
• Radi R, Cassina A, Hodara R, et al. Peroxynitrite reactions and formation in mitochondria. Free Radic Biol Med 2002;33:1451-64
   PubMed Web of Science ®Google Scholar
• Monteiro HP. Signal transduction by protein tyrosine nitration: competition or cooperation with tyrosine phosphorylation-dependent signaling events? Free Radic Biol Med 2002;33:765-73
   PubMedGoogle Scholar
• Greenacre SA, Ischiropoulos H. Tyrosine nitration: localisation, quantification, consequences for protein function and signal transduction. Free Radic Res 2001;34:541-81
   PubMed Web of Science ®Google Scholar
• Ischiropoulos H. Biological tyrosine nitration: a pathophysiological function of nitric oxide and reactive oxygen species. Arch Biochem Biophys 1998;356:1-11
   PubMed Web of Science ®Google Scholar
• Beckman JS. Oxidative damage and tyrosine nitration from peroxynitrite. Chem Res Toxicol 1996;9:836-44
   PubMed Web of Science ®Google Scholar
• Beck A, Bussat MC, Zorn N, et al. Characterization by liquid chromatography combined with mass spectrometry of monoclonal anti-IGF-1 receptor antibodies produced in CHO and NS0 cells. J Chromatogr B 2005;819:203-18
   PubMed Web of Science ®Google Scholar
• Wiegandt A, Meyer B. Unambiguous Characterization of N-glycans of monoclonal antibody cetuximab by integration of LC-MS/MS and 1H NMR spectroscopy. Anal Chem 2014;86:4807-14
   PubMedGoogle Scholar
• Váradi C, Lew C, Guttman A. Rapid magnetic bead based sample preparation for automated and high throughput N-glycan analysis of therapeutic antibodies. Anal Chem 2014;86(12):5682-7
   PubMed Web of Science ®Google Scholar
• Song T, Ozcan S, Becker A, Lebrilla CB. In-Depth Method for the Characterization of Glycosylation in Manufactured Recombinant Monoclonal Antibody Drugs. Anal Chem 2014;86:5661-6
   PubMed Web of Science ®Google Scholar
• Houel S, Hilliard M, Yu YQ, et al. N- and O-Glycosylation Analysis of Etanercept Using Liquid Chromatography and Quadrupole Time-of-Flight Mass Spectrometry Equipped with Electron-Transfer Dissociation Functionality. Anal Chem 2014;86:576-84
   PubMed Web of Science ®Google Scholar
• Gahoual R, Busnel JM, Beck A, et al. Full antibody primary structure and microvariant characterization in a single injection using transient isotachophoresis and sheathless capillary electrophoresis–tandem mass spectrometry. Anal Chem 2014;86:9074-81
   PubMed Web of Science ®Google Scholar
• Zauner G, Selman MH, Bondt A, et al. Glycoproteomic Analysis of Antibodies. Mol Cell Proteomics 2013;12:856-65
   PubMed Web of Science ®Google Scholar
• Patrie SM, Roth MJ, Kohler JJ. Introduction to glycosylation and mass spectrometry. Methods Mol Biol 2013;951:1-17
   PubMedGoogle Scholar
• Mao Y, Valeja SG, Rouse JC, et al. Top-down structural analysis of an intact monoclonal antibody by electron capture dissociation-fourier transform ion cyclotron resonance-mass spectrometry. Anal Chem 2013;85:4239-46
   PubMed Web of Science ®Google Scholar
• Leymarie N, Griffin PJ, Jonscher K, et al. Interlaboratory study on differential analysis of protein glycosylation by mass spectrometry: the ABRF glycoprotein research multi-institutional study 2012. Mol Cell Proteomics 2013;12:2935-51
   PubMed Web of Science ®Google Scholar
• Tsybin YO, Fornelli L, Stoermer C, et al. Structural analysis of intact monoclonal antibodies by electron transfer dissociation mass spectrometry. Anal Chem 2011;83:8919-27
   PubMed Web of Science ®Google Scholar
• Szabo Z, Guttman AS, Bones J, Karger BL. Rapid high-resolution characterization of functionally important monoclonal antibody N-glycans by capillary electrophoresis. Anal Chem 2011;83:5329-36
   PubMed Web of Science ®Google Scholar
• Melmer M, Stangler T, Schiefermeier M, et al. HILIC analysis of fluorescence-labeled N-glycans from recombinant biopharmaceuticals. Anal Bioanal Chem 2010;398:905-14
   PubMed Web of Science ®Google Scholar
• Jiang H, Wu SL, Karger BL, Hancock WS. Characterization of the Glycosylation Occupancy and the Active Site in the Follow-on Protein Therapeutic: TNK-Tissue Plasminogen Activator. Anal Chem 2010;82:6154-62
   PubMed Web of Science ®Google Scholar
• Gil GC, Velander WH, Van Cott KE. N-glycosylation microheterogeneity and site occupancy of an Asn-X-Cys sequon in plasma-derived and recombinant protein C. Proteomics 2009;9:2555-67
   PubMedGoogle Scholar
• Borisov OV, Field M, Ling VT, Harris RJ. Characterization of oligosaccharides in recombinant tissue plasminogen activator produced in Chinese hamster ovary cells: Two decades of analytical technology development. Anal Chem 2009;81:9744-54
   PubMedGoogle Scholar
• Srebalus Barnes CA, Lim A. Applications of mass spectrometry for the structural characterization of recombinant protein pharmaceuticals. Mass Spectrom Rev 2007;26:370-88
   PubMed Web of Science ®Google Scholar
• Fernandez LE, Kalume DE, Calvo L, et al. Characterization of a recombinant monoclonal antibody by mass spectrometry combined with liquid chromatography. J Chromatogr B 2001;752:247-61
   PubMedGoogle Scholar
• Werner RG, Noe W, Kopp K, Schluter M. Appropriate mammalian expression systems for biopharmaceuticals. Arzneim Fors Drug Res 1998;48:870-80
   PubMed Web of Science ®Google Scholar
• Fournier T, Guibourdenche J, Evain-Brion D. Review: hCGs: Different sources of production, different glycoforms and functions. Placenta 2015;36(Suppl 1):S60-5
   PubMedGoogle Scholar
• Wagner-Rousset E, Bednarczyk A, Bussat MC, et al. The way forward, enhanced characterization of therapeutic antibody glycosylation: comparison of three level mass spectrometry-based strategies. J Chromatogr B 2008;872:23-37
   PubMed Web of Science ®Google Scholar
• Beck A, Wagner-Rousset E, Bussat MC, et al. Trends in glycosylation, glycoanalysis and glycoengineering of therapeutic antibodies and Fc-fusion proteins. Curr Pharm Biotechnol 2008;9:482-501
   PubMed Web of Science ®Google Scholar
• Fares F. The role of O-linked and N-linked oligosaccharides on the structure-function of glycoprotein hormones: development of agonists and antagonists. Bio Biophy Acta 2006;1760:560-7
   PubMedGoogle Scholar
• Sinclair AM, Elliott S. Glycoengineering: the effect of glycosylation on the properties of therapeutic proteins. J Pharm Sci 2005;94:1626-35
   PubMed Web of Science ®Google Scholar
• Gervais A, Hammel YA, Pelloux S, et al. Glycosylation of human recombinant gonadotrophins: characterization and batch-to-batch consistency. Glycobiology 2003;13:179-89
   PubMedGoogle Scholar
• Ulloa-Aguirre A, Timossi C, Damian-Matsumura P, Dias JA. Role of glycosylation in function of follicle-stimulating hormone. Endocrine 1999;11:205-15
   PubMed Web of Science ®Google Scholar
• Storring PL. Assaying glycoprotein hormones--the influence of glycosylation on immunoreactivity. Trends Biotechnol 1992;10:427-32
   PubMedGoogle Scholar
• Takeuchi M, Kobata A. Structures and functional roles of the sugar chains of human erythropoietins. Glycobiology 1991;1:337-46
   PubMedGoogle Scholar
• Cao Q, Zhao X, Zhao Q, et al. Strategy integrating stepped fragmentation and glycan diagnostic ion-based spectrum refinement for the identification of core fucosylated glycoproteome using mass spectrometry. Anal Chem 2014;86:6804-11
   PubMedGoogle Scholar
• McCarthy C, Saldova R, Wormald MR, et al. The role and importance of glycosylation of acute phase proteins with focus on alpha-1 antitrypsin in acute and chronic inflammatory conditions. J Proteome Res 2014;13:3131-43
   PubMedGoogle Scholar
• Ahn JM, Sung HJ, Yoon YH, et al. Integrated Glycoproteomics Demonstrates Fucosylated Serum Paraoxonase 1 Alterations in Small Cell Lung Cancer. Mol Cell Proteomics 2014;13:30-48
   PubMed Web of Science ®Google Scholar
• Ruhaak LR, Miyamoto S, Lebrilla CB. Developments in the Identification of Glycan Biomarkers for the Detection of Cancer. Mol Cell Proteomics 2013;12:846-55
   PubMed Web of Science ®Google Scholar
• Chen K, Gentry-Maharaj A, Burnell M, et al. Microarray glycoprofiling of CA125 improves differential diagnosis of ovarian cancer. J Proteome Res 2013;12:1408-18
   PubMed Web of Science ®Google Scholar
• Wu J, Xie X, Liu Y, et al. Identification and confirmation of differentially expressed fucosylated glycoproteins in the serum of ovarian cancer patients using a lectin array and LC-MS/MS. J Proteome Res 2012;11:4541-52
   PubMedGoogle Scholar
• Balog CI, Stavenhagen K, Fung WL, et al. N-glycosylation of colorectal cancer tissues. Mol Cell Proteomics 2012;11:571-85
   PubMed Web of Science ®Google Scholar
• Alley WR, Vasseur JA, Goetz JA, et al. N-linked glycan structures and their expressions change in the blood sera of ovarian cancer patients. J Proteome Res 2012;11:2282-300
   PubMed Web of Science ®Google Scholar
• Wagner KW, Punnoose EA, Januario T, et al. Death-receptor O-glycosylation controls tumor-cell sensitivity to the proapoptotic ligand Apo2L/TRAIL. Nat Med 2007;13:1070-7
   PubMed Web of Science ®Google Scholar
• Heo SH, Lee SJ, Ryoo HM, et al. Identification of putative serum glycoprotein biomarkers for human lung adenocarcinoma by multilectin affinity chromatography and LC-MS/MS. Proteomics 2007;7:4292-302
   PubMed Web of Science ®Google Scholar
• Li Y, Tian Y, Rezai T, et al. Simultaneous analysis of glycosylated and sialylated prostate-specific antigen revealing differential distribution of glycosylated prostate-specific antigen isoforms in prostate cancer tissues. Anal Chem 2010;83:240-5
   PubMedGoogle Scholar
• Bones J, Mittermayr S, O’Donoghue N, et al. Ultra performance liquid chromatographic profiling of serum N-glycans for fast and efficient identification of cancer associated alterations in glycosylation. Anal Chem 2010;82:10208-15
   PubMed Web of Science ®Google Scholar
• Arnold JN, Saldova R, Galligan MC, et al. Novel glycan biomarkers for the detection of lung cancer. J Proteome Res 2011;10:1755-64
   PubMed Web of Science ®Google Scholar
• Stanta JL, Saldova R, Struwe WB, et al. Identification of N-Glycosylation Changes in the CSF and Serum in Patients with Schizophrenia. J Proteome Res 2010;9:4476-89
   PubMed Web of Science ®Google Scholar
• de Leoz ML, Young LJT, An HJ, et al. High-mannose glycans are elevated during breast cancer progression. Mol Cell Proteomics 2011;10:10
   Google Scholar
• Abbott KL, Lim JM, Wells L, et al. Identification of candidate biomarkers with cancer-specific glycosylation in the tissue and serum of endometrioid ovarian cancer patients by glycoproteomic analysis. Proteomics 2010;10:470-81
   PubMed Web of Science ®Google Scholar
• Liu Y, He J, Li C, et al. Identification and Confirmation of Biomarkers Using an Integrated Platform for Quantitative Analysis of Glycoproteins and Their Glycosylations. J Proteome Res 2009;9:798-805
   Google Scholar
• Tang Z, Varghese RS, Bekesova S, et al. Identification of N-glycan serum markers associated with hepatocellular carcinoma from mass spectrometry data. J Proteome Res 2009;9:104-12
   Google Scholar
• Ahn YH, Lee JY, Lee JY, et al. Quantitative analysis of an aberrant glycoform of TIMP1 from colon cancer serum by L-PHA-enrichment and SISCAPA with MRM mass spectrometry. J Proteome Res 2009;8:4216-24
   PubMed Web of Science ®Google Scholar
• Mechref Y, Hussein A, Bekesova S, et al. Quantitative serum glycomics of esophageal adenocarcinoma and other esophageal disease onsets. J Proteome Res 2009;8:2656-66
   PubMed Web of Science ®Google Scholar
• Ueda K, Fukase Y, Katagiri T, et al. Targeted serum glycoproteomics for the discovery of lung cancer-associated glycosylation disorders using lectin-coupled ProteinChip arrays. Proteomics 2009;9:2182-92
   PubMedGoogle Scholar
• Kuzmanov U, Jiang N, Smith CR, et al. Differential N-glycosylation of Kallikrein 6 derived from ovarian cancer cells or the central nervous system. Mol Cell Proteomics 2009;8:791-8
   PubMedGoogle Scholar
• Matsumoto K, Shimizu C, Arao T, et al. Identification of predictive biomarkers for response to trastuzumab using plasma FUCA activity and N-glycan identified by MALDI-TOF-MS. J Proteome Res 2009;8:457-62
   PubMedGoogle Scholar
• Qiu Y, Patwa TH, Xu L, et al. Plasma glycoprotein profiling for colorectal cancer biomarker identification by lectin glycoarray and lectin blot. J Proteome Res 2008;7:1693-703
   PubMed Web of Science ®Google Scholar
• Kaji H, Isobe T. Liquid chromatography/mass spectrometry (LC/MS)-based glycoproteomics technologies for cancer biomarker discovery. Clin Proteomics 2008;4:14-24
   Google Scholar
• Kreunin P, Zhao J, Rosser C, et al. Bladder cancer associated glycoprotein signatures revealed by urinary proteomic profiling. J Proteome Res 2007;6:2631-9
   PubMed Web of Science ®Google Scholar
• Abbott KL, Aoki K, Lim JM, et al. Targeted Glycoproteomic Identification of Biomarkers for Human Breast Carcinoma. J Proteome Res 2008;7:1470-80
   PubMed Web of Science ®Google Scholar
• Norton PA, Comunale MA, Krakover J, et al. N-linked glycosylation of the liver cancer biomarker GP73. J Cell Biochem 2008;104:136-49
   PubMed Web of Science ®Google Scholar
• Saldova R, Royle L, Radcliffe CM, et al. Ovarian Cancer is Associated With Changes in Glycosylation in Both Acute-Phase Proteins and IgG. Glycobiology 2007;17:1344-56
   PubMed Web of Science ®Google Scholar
• An HJ, Miyamoto S, Lancaster KS, et al. Profiling of glycans in serum for the discovery of potential biomarkers for ovarian cancer. J Proteome Res 2006;5:1626-35
   PubMed Web of Science ®Google Scholar
• Yang Z, Harris LE, Palmer-Toy DE, Hancock WS. Multilectin affinity chromatography for characterization of multiple glycoprotein biomarker candidates in serum from breast cancer patients. Clin Chem 2006;52:1897-905
   PubMedGoogle Scholar
• Comunale MA, Lowman M, Long RE, et al. Proteomic analysis of serum associated fucosylated glycoproteins in the development of primary hepatocellular carcinoma. J Proteome Res 2006;5:308-15
   PubMedGoogle Scholar
• Troyer DA, Mubiru J, Leach RJ, Naylor SL. Promise and challenge: Markers of prostate cancer detection, diagnosis and prognosis. Dis Markers 2004;20:117-28
   PubMedGoogle Scholar
• Marian M, Seghezzi W. Novel Biopharmaceuticals: Pharmacokinetics, Pharmacodynamics, and Bioanalytics. In: Plitnick LM, Herzyk DJ, Chapter 4 in: Nonclinical development of novel biologics, biosimilars, vaccines and specialty biologics. Academic Press; San Diego: 2013. p. 97-137
   Google Scholar
• Bults PB, Bakker H, van de Merbel NC. In vitro and in vivo deamidation of the biopharmaceutical antibody Trastuzumab. In preparation 2015
   Google Scholar
• Bischoff R, Clesse D, Whitechurch O, et al. Isolation of recombinant hirudin by preparative high-performance liquid chromatography. J Chromatogr B 1989;476:245-55
   Google Scholar
• Beck A, Sanglier-Cianferani S, Van Dorsselaer A. Biosimilar, biobetter, and next generation antibody characterization by mass spectrometry. Anal Chem 2012;84:4637-46
   PubMed Web of Science ®Google Scholar
• Leary BA, Lawrence-Henderson R, Mallozzi C, et al. Bioanalytical platform comparison using a generic human IgG PK assay format. J Immunol Methods 2013;397:28-36
   PubMed Web of Science ®Google Scholar
• Prudom C, Liu J, Patrie J, et al. Comparison of competitive radioimmunoassays and two-site sandwich assays for the measurement and interpretation of plasma ghrelin levels. J Clin Endocrinol Metab 2010;95:2351-8
   PubMedGoogle Scholar
• Fischer SK, Yang J, Anand B, et al. The assay design used for measurement of therapeutic antibody concentrations can affect pharmacokinetic parameters: Case studies. mAbs 2012;4:623-31
   PubMed Web of Science ®Google Scholar
• Sukovaty RL, Lee JW, Fox J, et al. Quantification of recombinant human parathyroid hormone (rhPTH(1-84)) in human plasma by immunoassay: commercial kit evaluation and validation to support pharmacokinetic studies. J Pharm Biomed Anal 2006;42:261-71
   PubMedGoogle Scholar
• Ouyang Z, Furlong MT, Wu S, et al. Pellet digestion: a simple and efficient sample preparation technique for LC-MS/MS quantification of large therapeutic proteins in plasma. Bioanalysis 2012;4:17-28
   PubMed Web of Science ®Google Scholar
• Li H, Ortiz R, Tran L, et al. General LC-MS/MS method approach to quantify therapeutic monoclonal antibodies using a common whole antibody internal standard with application to preclinical studies. Anal Chem 2012;84:1267-73
   PubMed Web of Science ®Google Scholar
• Bronsema KJ, Schlaman R, Schalk J, et al. Development, validation and application of a quantitative LC-MS/MS method for insulin like growth factor-1 in human plasma. in preparation 2015
   Google Scholar
• Wang SJ, Wu ST, Gokemeijer J, et al. Attribution of the discrepancy between ELISA and LC-MS/MS assay results of a PEGylated scaffold protein in post-dose monkey plasma samples due to the presence of anti-drug antibodies. Anal Bioanal Chem 2012;402:1229-39
   PubMedGoogle Scholar
• Cabaleiro DR, Stöckl D, Kaufman JM, et al. Feasibility of standardization of serum C-peptide immunoassays with isotope-dilution liquid chromatography-tandem mass spectrometry. Clin Chem 2006;52:1193-6
   PubMedGoogle Scholar
• Kroot JJ, Laarakkers CM, Geurts-Moespot AJ, et al. Immunochemical and mass-spectrometry-based serum hepcidin assays for iron metabolism disorders. Clin Chem 2010;56:1570-9
   PubMed Web of Science ®Google Scholar
• Liu Y, Buil A, Collins BC, et al. Quantitative variability of 342 plasma proteins in a human twin population. Mol Syst Biol 2015;11:1-18
   Google Scholar
• Carr SA, Abbatiello SE, Ackermann BL, et al. Targeted Peptide Measurements in Biology and Medicine: Best Practices for Mass Spectrometry-based Assay Development Using a Fit-for-Purpose Approach. Mol Cell Proteomics 2014;13:907-17
   PubMed Web of Science ®Google Scholar
• Surinova S, Huttenhain R, Chang CY, et al. Automated selected reaction monitoring data analysis workflow for large-scale targeted proteomic studies. Nat Protoc 2013;8:1602-19
   PubMed Web of Science ®Google Scholar
• Picotti P, Aebersold R. Selected reaction monitoring-based proteomics: workflows, potential, pitfalls and future directions. Nat Methods 2012;9:555-66
   PubMed Web of Science ®Google Scholar
• Malmstrom L, Malmstrom J, Selevsek N, et al. Automated Workflow for Large-Scale Selected Reaction Monitoring Experiments. J Proteome Res 2012;11:1644-53
   PubMedGoogle Scholar
• Gillet LC, Navarro P, Tate S, et al. Targeted data extraction of the MS/MS spectra generated by data-independent acquisition: a new concept for consistent and accurate proteome analysis. Mol Cell Proteomics 2012;11:10
   Google Scholar
• Siegel D, Meinema AC, Permentier HP, et al. Integrated quantification and identification of aldehydes and ketones in biological samples. Anal Chem 2014;86:5089-100
   PubMed Web of Science ®Google Scholar
• Lesur A, Domon B. Advances in high-resolution accurate mass spectrometry application to targeted proteomics. Proteomics 2014;15(5-6):880-90
   Google Scholar
• Tarasow TM, Penny L, Patwardhan A, et al. Microfluidic strategies applied to biomarker discovery and validation for multivariate diagnostics. Bioanalysis 2011;3:2233-51
   PubMedGoogle Scholar